CN Patent

CN102725296B — 对蛋白激酶有抑制活性的噻吩并[3,2-d]嘧啶衍生物

Assigned to Korea Institute of Science and Technology KIST · Expires 2015-04-01 · 11y expired

What this patent protects

本发明涉及对蛋白激酶有极佳抑制活性的式(I)的噻吩并[3，2-d]嘧啶衍生物或者其可药用盐、水合物或溶剂化物，以及包含其的药物组合物在预防或治疗细胞生长异常疾病中有效。

USPTO Abstract

本发明涉及对蛋白激酶有极佳抑制活性的式(I)的噻吩并[3，2-d]嘧啶衍生物或者其可药用盐、水合物或溶剂化物，以及包含其的药物组合物在预防或治疗细胞生长异常疾病中有效。

Drugs covered by this patent

Patent Metadata

Patent number
CN102725296B
Jurisdiction
CN
Classification
—
Expires
2015-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Korea Institute of Science and Technology KIST
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.